CN111820407A - 一种抗幽门螺旋杆菌组合物及其应用 - Google Patents
一种抗幽门螺旋杆菌组合物及其应用 Download PDFInfo
- Publication number
- CN111820407A CN111820407A CN202010892402.2A CN202010892402A CN111820407A CN 111820407 A CN111820407 A CN 111820407A CN 202010892402 A CN202010892402 A CN 202010892402A CN 111820407 A CN111820407 A CN 111820407A
- Authority
- CN
- China
- Prior art keywords
- extract
- helicobacter pylori
- lactobacillus
- composition according
- bifidobacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229940037467 helicobacter pylori Drugs 0.000 title claims abstract description 92
- 241000590002 Helicobacter pylori Species 0.000 title claims abstract description 69
- 239000000203 mixture Substances 0.000 title claims abstract description 64
- 239000000284 extract Substances 0.000 claims abstract description 134
- 241000196324 Embryophyta Species 0.000 claims abstract description 43
- 239000006041 probiotic Substances 0.000 claims abstract description 37
- 235000018291 probiotics Nutrition 0.000 claims abstract description 37
- 239000013543 active substance Substances 0.000 claims abstract description 33
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 32
- 235000007303 Thymus vulgaris Nutrition 0.000 claims abstract description 22
- 239000001585 thymus vulgaris Substances 0.000 claims abstract description 22
- 235000020240 turmeric extract Nutrition 0.000 claims abstract description 22
- 239000008513 turmeric extract Substances 0.000 claims abstract description 21
- 229940052016 turmeric extract Drugs 0.000 claims abstract description 21
- 239000000126 substance Substances 0.000 claims abstract description 17
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 240000002657 Thymus vulgaris Species 0.000 claims abstract description 3
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 26
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 26
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 26
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 26
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 26
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 26
- 239000001814 pectin Substances 0.000 claims description 25
- 229920001277 pectin Polymers 0.000 claims description 25
- 235000010987 pectin Nutrition 0.000 claims description 25
- 235000020691 dandelion extract Nutrition 0.000 claims description 24
- 229940067866 dandelion extract Drugs 0.000 claims description 24
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 24
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 20
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 20
- 241000246044 Sophora flavescens Species 0.000 claims description 18
- 235000019206 astragalus extract Nutrition 0.000 claims description 16
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 14
- 244000247747 Coptis groenlandica Species 0.000 claims description 14
- 230000000529 probiotic effect Effects 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 235000008708 Morus alba Nutrition 0.000 claims description 6
- 240000000249 Morus alba Species 0.000 claims description 6
- 244000057717 Streptococcus lactis Species 0.000 claims description 6
- 235000014897 Streptococcus lactis Nutrition 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 6
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims description 6
- -1 isomaltulose oligosaccharide Chemical class 0.000 claims description 6
- 229920001542 oligosaccharide Polymers 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- 229920001202 Inulin Polymers 0.000 claims description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 5
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 5
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 5
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 5
- 229940029339 inulin Drugs 0.000 claims description 5
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- 235000010356 sorbitol Nutrition 0.000 claims description 5
- 239000000811 xylitol Substances 0.000 claims description 5
- 235000010447 xylitol Nutrition 0.000 claims description 5
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 5
- 229960002675 xylitol Drugs 0.000 claims description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 4
- 235000005979 Citrus limon Nutrition 0.000 claims description 4
- 244000131522 Citrus pyriformis Species 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- 210000001541 thymus gland Anatomy 0.000 claims description 4
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 claims description 3
- FVVCFHXLWDDRHG-UPLOTWCNSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4r,5r,6r)-6-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 FVVCFHXLWDDRHG-UPLOTWCNSA-N 0.000 claims description 3
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 claims description 3
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 claims description 3
- 241000589220 Acetobacter Species 0.000 claims description 3
- 244000235858 Acetobacter xylinum Species 0.000 claims description 3
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims description 3
- 241000205585 Aquilegia canadensis Species 0.000 claims description 3
- 229920000189 Arabinogalactan Polymers 0.000 claims description 3
- 239000001904 Arabinogalactan Substances 0.000 claims description 3
- 241000228212 Aspergillus Species 0.000 claims description 3
- 240000006439 Aspergillus oryzae Species 0.000 claims description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 3
- 241000186018 Bifidobacterium adolescentis Species 0.000 claims description 3
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 3
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims description 3
- 240000007124 Brassica oleracea Species 0.000 claims description 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 3
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 3
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 3
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 3
- 235000007542 Cichorium intybus Nutrition 0.000 claims description 3
- 244000298479 Cichorium intybus Species 0.000 claims description 3
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims description 3
- 244000077995 Coix lacryma jobi Species 0.000 claims description 3
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 claims description 3
- 241001523681 Dendrobium Species 0.000 claims description 3
- 244000268590 Euryale ferox Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 240000000588 Hericium erinaceus Species 0.000 claims description 3
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 3
- 241000334160 Isatis Species 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 240000001929 Lactobacillus brevis Species 0.000 claims description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 claims description 3
- 244000199885 Lactobacillus bulgaricus Species 0.000 claims description 3
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 claims description 3
- 244000199866 Lactobacillus casei Species 0.000 claims description 3
- 235000013958 Lactobacillus casei Nutrition 0.000 claims description 3
- 241000186606 Lactobacillus gasseri Species 0.000 claims description 3
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 3
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 3
- 240000002624 Mespilus germanica Species 0.000 claims description 3
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 3
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 3
- 241000192001 Pediococcus Species 0.000 claims description 3
- 235000008599 Poria cocos Nutrition 0.000 claims description 3
- 244000197580 Poria cocos Species 0.000 claims description 3
- 229920001218 Pullulan Polymers 0.000 claims description 3
- 239000004373 Pullulan Substances 0.000 claims description 3
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims description 3
- 235000003713 Rhodiola rosea Nutrition 0.000 claims description 3
- 244000042430 Rhodiola rosea Species 0.000 claims description 3
- 241000194020 Streptococcus thermophilus Species 0.000 claims description 3
- 244000223014 Syzygium aromaticum Species 0.000 claims description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 3
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims description 3
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 3
- 235000019312 arabinogalactan Nutrition 0.000 claims description 3
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 claims description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 3
- 229940004120 bifidobacterium infantis Drugs 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 229940094952 green tea extract Drugs 0.000 claims description 3
- 235000020688 green tea extract Nutrition 0.000 claims description 3
- 239000000832 lactitol Substances 0.000 claims description 3
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 3
- 235000010448 lactitol Nutrition 0.000 claims description 3
- 229960003451 lactitol Drugs 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 claims description 3
- 229940017800 lactobacillus casei Drugs 0.000 claims description 3
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 3
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 3
- 229960000511 lactulose Drugs 0.000 claims description 3
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 3
- 229920005610 lignin Polymers 0.000 claims description 3
- 229940105902 mint extract Drugs 0.000 claims description 3
- 235000019423 pullulan Nutrition 0.000 claims description 3
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims description 3
- 229960002920 sorbitol Drugs 0.000 claims description 3
- 241000190633 Cordyceps Species 0.000 claims description 2
- 235000020717 hawthorn extract Nutrition 0.000 claims description 2
- 241000555682 Forsythia x intermedia Species 0.000 claims 1
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims 1
- 229940104640 chinese yam extract Drugs 0.000 claims 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 1
- 235000011477 liquorice Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 230000002401 inhibitory effect Effects 0.000 abstract description 12
- 235000019629 palatability Nutrition 0.000 abstract description 11
- 210000000214 mouth Anatomy 0.000 abstract description 9
- 230000002147 killing effect Effects 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 241000589989 Helicobacter Species 0.000 abstract description 2
- 239000011159 matrix material Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical group C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 26
- 241000246358 Thymus Species 0.000 description 19
- 239000000668 oral spray Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 14
- 235000012754 curcumin Nutrition 0.000 description 13
- 239000004148 curcumin Substances 0.000 description 13
- 229940109262 curcumin Drugs 0.000 description 13
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 13
- 229940041678 oral spray Drugs 0.000 description 13
- 238000000034 method Methods 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 239000002253 acid Substances 0.000 description 8
- 230000002496 gastric effect Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 210000001156 gastric mucosa Anatomy 0.000 description 6
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 235000019640 taste Nutrition 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 229930013930 alkaloid Natural products 0.000 description 5
- 229910021529 ammonia Inorganic materials 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 229960000448 lactic acid Drugs 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000011241 protective layer Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 4
- 102000016938 Catalase Human genes 0.000 description 4
- 108010053835 Catalase Proteins 0.000 description 4
- 241000037740 Coptis chinensis Species 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 108010046334 Urease Proteins 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 150000003797 alkaloid derivatives Chemical class 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000013329 compounding Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229930004725 sesquiterpene Natural products 0.000 description 4
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- XDVZNDLANFJOQR-UHFFFAOYSA-N Coptisine Natural products O=Cc1c2OCOc2ccc1C=C3/NCCc4cc5OCOc5cc34 XDVZNDLANFJOQR-UHFFFAOYSA-N 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 3
- 229940116229 borneol Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229940126673 western medicines Drugs 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- 241001633583 Adenophora Species 0.000 description 2
- 102100026189 Beta-galactosidase Human genes 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 102000016622 Dipeptidyl Peptidase 4 Human genes 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 235000006487 Euryale ferox Nutrition 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 108010059881 Lactase Proteins 0.000 description 2
- 201000010538 Lactose Intolerance Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 241000219784 Sophora Species 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QMNWISYXSJWHRY-YLNUDOOFSA-N astragaloside IV Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)[C@H]4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C[C@H]3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-YLNUDOOFSA-N 0.000 description 2
- QMNWISYXSJWHRY-BCBPIKMJSA-N astragaloside IV Natural products CC(C)(O)[C@@H]1CC[C@@](C)(O1)[C@H]2[C@@H](O)C[C@@]3(C)[C@@H]4C[C@H](O[C@@H]5O[C@H](CO)[C@H](O)[C@@H](O)[C@H]5O)[C@H]6C(C)(C)[C@H](CC[C@@]67C[C@@]47CC[C@]23C)O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O QMNWISYXSJWHRY-BCBPIKMJSA-N 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- LUXPUVKJHVUJAV-UHFFFAOYSA-M coptisine, chloride Chemical compound [Cl-].C1=C2C=C(C3=C(C=C4OCOC4=C3)CC3)[N+]3=CC2=C2OCOC2=C1 LUXPUVKJHVUJAV-UHFFFAOYSA-M 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- PFKIBRPYVNVMRU-UHFFFAOYSA-N cyclosieversioside F Natural products CC(C)(O)C1COC(C)(C1)C2C(O)CC3(C)C4CC(OC5OC(CO)C(O)C(O)C5O)C6C(C)(C)C(CCC67CC47CCC23C)OC8OCC(O)C(O)C8O PFKIBRPYVNVMRU-UHFFFAOYSA-N 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000003495 flagella Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 229940116108 lactase Drugs 0.000 description 2
- 229940069445 licorice extract Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002972 pentoses Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 description 2
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 description 1
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102000016912 Aldehyde Reductase Human genes 0.000 description 1
- 108010053754 Aldehyde reductase Proteins 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 241000615866 Antho Species 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 241001495180 Arthrospira Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- GYFSYEVKFOOLFZ-UHFFFAOYSA-N Berberrubine Chemical compound [Cl-].C1=C2CC[N+]3=CC4=C(O)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 GYFSYEVKFOOLFZ-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 239000009513 Coptidis rhizoma extract Substances 0.000 description 1
- 235000007106 Crataegus suborbiculata Nutrition 0.000 description 1
- 241000073432 Crataegus suborbiculata Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000007342 Diabetic Nephropathies Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010017636 Gallbladder obstruction Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 101000930822 Giardia intestinalis Dipeptidyl-peptidase 4 Proteins 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019375 Helicobacter infections Diseases 0.000 description 1
- 229920000869 Homopolysaccharide Polymers 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- MXTLAHSTUOXGQF-UHFFFAOYSA-O Jatrorrhizine Chemical compound COC1=CC=C2C=C3C(C=C(C(=C4)O)OC)=C4CC[N+]3=CC2=C1OC MXTLAHSTUOXGQF-UHFFFAOYSA-O 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038468 Renal hypertrophy Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000607493 Vibrionaceae Species 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000013202 a hawthorn Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940047169 astragalus root extract Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- GLYPKDKODVRYGP-UHFFFAOYSA-O berberrubine Natural products C1=C2CC[N+]3=CC4=C(O)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 GLYPKDKODVRYGP-UHFFFAOYSA-O 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- GLYPKDKODVRYGP-UHFFFAOYSA-N burberrubine Natural products C12=CC=3OCOC=3C=C2CCN2C1=CC1=CC=C(OC)C(=O)C1=C2 GLYPKDKODVRYGP-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000033679 diabetic kidney disease Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 125000005594 diketone group Chemical group 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- FPJQGFLUORYYPE-UHFFFAOYSA-N epiberberine Chemical compound C1=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C2OCOC2=C1 FPJQGFLUORYYPE-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 201000008627 kidney hypertrophy Diseases 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 210000003584 mesangial cell Anatomy 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 150000002773 monoterpene derivatives Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229930015582 oxymatrine Natural products 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-M phenolate Chemical compound [O-]C1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-M 0.000 description 1
- 229940031826 phenolate Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000003140 primary amides Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- 235000008151 pyridoxamine Nutrition 0.000 description 1
- 239000011699 pyridoxamine Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000152 swallowing effect Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 150000004044 tetrasaccharides Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229910021654 trace metal Inorganic materials 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3202—Prebiotics, ingredients fermented in the gastrointestinal tract by beneficial microflora
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
- A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/208—Fungi extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/503—Arabinogalactan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5062—Inulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5072—Pectine, pectinate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5076—Pullulane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/614—Lactulose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/628—Saccharose, sucrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/632—Stachyose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/638—Xylose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6414—Lactitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/642—Sorbitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
- A23V2250/64—Sugar alcohols
- A23V2250/6422—Xylitol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/76—Yeasts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及抗幽门螺旋杆菌的组合物技术领域,具体涉及一种抗幽门螺旋杆菌组合物及其应用。一种抗幽门螺旋杆菌组合物,以植物活性物质为基质,所述植物活性物质至少包括百里香提取物和姜黄提取物;同时复配一定量的益生元和益生菌。本发明提供了一种抗幽门螺旋杆菌组合物,可应用于食品和日化用品领域,具有较好的稳定性和适口性,在日常生活中即可有效的抑制、杀灭幽门螺旋杆菌。本发明提供的抗幽门螺旋杆菌组合物能够有效抑制、杀灭整个口腔牙缝部位的幽门螺旋杆菌,对幽门螺旋杆菌的抑制、杀灭率高达99%,且无任何毒副作用,具有较好的应用价值。
Description
技术领域
本发明涉及抗幽门螺旋杆菌组合物技术领域,具体涉及一种抗幽门螺旋杆菌组合物及其应用。
背景技术
幽门螺旋杆菌属弧菌科、螺杆菌属。格兰氏阴性菌,呈弯曲,轻微螺旋状,长2.5~5mm、粗0.5mm。菌体一端或两端有多根鞭毛,运动活泼,以鞭毛提供动力,穿过黏液层,通常寄生在黏液层下方,黏膜上皮表面,在胃小凹内及腺腔内,呈不均匀团状分布。现有研究表明,十二指肠溃疡或胃溃疡或胃癌均与幽门杆菌有密切关系。胃幽门螺旋杆菌可黏附于胃黏膜上皮细胞,因此可避免随食物被胃排空;幽门螺旋杆菌分泌过氧化氢酶、脂肪酶、磷酸酶、蛋白水解酶及毒素等,均会损伤胃黏膜上皮细胞;还可透过尿素酶水解尿素产生氨,在菌体周遭形成“氨云”保护层,以抵抗胃酸的杀菌作用。
目前在治疗幽门螺旋杆菌的方法上,多采取西医的、以抗生素为主的药物疗法,抗生素辅加抑酸剂及铋剂,联合用药、口服给药,主要治疗方案为三联或四联疗法,但西医抗生素疗法有如下弊端:一是抗生素滥用现象明显,细菌耐药率高,效果会越来越不理想;二是西药容易对肝功能造成损伤,还可能会有过敏反应,以及因服药造成肠胃道菌群失调,导致腹泻、肾功能损伤等等;三,不控制杆菌从口进入、感染,西药治疗后,可能再次因饮食感染杆菌。目前无证据表明,西药治疗好杆菌后不会再次感染杆菌。
针对上述问题,本发明针对幽门螺旋杆菌感染泛滥,从预防、抑制的角度,提供了一种以植物活性物质为主,无毒副作用,在日常生活中即可有效的抑制、杀灭幽门螺旋杆菌的组合物。
发明内容
为了解决上述技术问题,本发明的第一个方面提供了一种抗幽门螺旋杆菌组合物,所述组合物的制备原料,按重量份计,至少包括以下组分:植物活性物质60-100份、益生元30-80份、益生菌10-40份;所述植物活性物质至少包括百里香提取物。
作为本发明一种优选的技术方案,所述植物活性物质还包括姜黄提取物、甘蓝提取物、桑葚提取物、菊苣提取物、佛手提取物、蒲公英提取物、石斛提取物、灵芝提取物、丁香提取物、陈皮提取物、桑叶提取物、茯苓提取物、芡实提取物、沙参提取物、黄精提取物、蒲公英提取物、柠檬提取物、西蓝花提取物、金银花提取物、绿茶提取物、猴头菇提取物、薄荷提取物、甘草提取物、红景天提取物、枸杞提取物、虫草菌提取物、黄芪提取物、薏仁提取物、山楂提取物、山药提取物、连翘提取物、苦参提取物、黄连提取物、板蓝根提取物中的至少一种。
作为本发明一种优选的技术方案,所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,重量比为1:(0.5-5):(0.1-2):(0.5-3):(0.1-1.5):(0.05-1)。
作为本发明一种优选的技术方案,所述益生元选自木糖醇、山梨糖醇、乳糖醇、乳果糖、乳蔗糖、蜜二糖、木二糖、水苏糖、蜜三糖、低聚果糖、低聚半乳糖、低聚异麦芽糖、低聚木糖、低聚异麦芽酮糖、低聚龙胆糖、阿拉伯半乳聚糖、果胶、普鲁兰多糖、菊粉、木素中的至少一种。
作为本发明一种优选的技术方案,所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:(1-5):(1-5)。
作为本发明一种优选的技术方案,所述益生菌选自嗜酸乳杆菌、保加利亚乳杆菌、植物乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、干酪乳杆菌、格氏乳杆菌、约氏乳杆菌、唾液乳杆菌、短乳杆菌、乳酸链球菌、枯草芽孢杆菌、两歧双歧杆菌、青春双歧杆菌、婴儿双歧杆菌、短双歧杆菌、长双歧杆菌、罗门螺杆菌、乳双歧杆菌、格式乳杆菌、纹膜醋杆菌、木葡糖醋酸杆菌、啤酒片球菌、酿酒酵母、嗜热链球菌、米曲霉菌、安卡红曲霉、乳酸乳球菌中的至少一种。
作为本发明一种优选的技术方案,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:(0.5-2)。
作为本发明一种优选的技术方案,所述益生元和益生菌的重量比为(1-5):1。
本发明的第二个方面提供了所述抗幽门螺旋杆菌组合物的应用,应用于食品、日化用品领域。
作为本发明一种优选的技术方案,所述抗幽门螺旋杆菌组合物的添加量为0.1-20wt%。
有益效果
本发明提供了一种抗幽门螺旋杆菌组合物,主要由植物活性物质、益生元和益生菌制备得到,可应用于食品和日化用品领域,具有较好的稳定性和适口性,在日常生活中即可有效的抑制、杀灭幽门螺旋杆菌。本发明提供的抗幽门螺旋杆菌组合物能够有效抑制、杀灭整个口腔牙缝部位的幽门螺旋杆菌;其次,通过人体的吞咽动作进入肠胃部,能够改善肠道内微生物种群比例,增加益生菌的定殖,抑制病原菌幽门螺旋杆菌的生长,同时还能分泌多种酸性物质,使黏膜细胞之胃液分泌量降低,不会产生过多胃液侵蚀胃黏膜细胞,让细胞处于非疲劳状态,且能够有效破坏幽门螺旋杆菌所产生的保护层,使其无法抵抗胃液的杀菌作用,进一步抑制、杀灭肠胃部的幽门螺旋杆菌,具有安全无害、灭菌彻底、疗效显著的特点;另外,本发明采用多种植物活性成分的复配,通过抑制幽门螺旋杆菌的葡萄糖及糖代谢中间产物的氧化过程直接抑制或杀灭幽门螺旋杆菌,还可以通过降低幽门螺旋杆菌的毒力、抑制幽门螺旋杆菌的粘附能力、改变幽门螺旋杆菌的生存环境、抑制幽门螺旋杆菌的耐药性,从而抑杀幽门螺旋杆菌。本发明提供的组合物能够有效预防、抑制、杀灭幽门螺旋杆菌,对幽门螺旋杆菌的抑制、杀灭率高达99%,且无任何毒副作用,具有较好的应用价值。
具体实施方式
参选以下本发明的优选实施方法的详述以及包括的实施例可更容易地理解本发明的内容。除非另有限定,本文使用的所有技术以及科学术语具有与本发明所属领域普通技术人员通常理解的相同的含义。当存在矛盾时,以本说明书中的定义为准。
如本文所用术语“由…制备”与“包含”同义。本文中所用的术语“包含”、“包括”、“具有”、“含有”或其任何其它变形,意在覆盖非排它性的包括。例如,包含所列要素的组合物、步骤、方法、制品或装置不必仅限于那些要素,而是可以包括未明确列出的其它要素或此种组合物、步骤、方法、制品或装置所固有的要素。
连接词“由…组成”排除任何未指出的要素、步骤或组分。如果用于权利要求中,此短语将使权利要求为封闭式,使其不包含除那些描述的材料以外的材料,但与其相关的常规杂质除外。当短语“由…组成”出现在权利要求主体的子句中而不是紧接在主题之后时,其仅限定在该子句中描述的要素;其它要素并不被排除在作为整体的所述权利要求之外。
当量、浓度、或者其它值或参数以范围、优选范围、或一系列上限优选值和下限优选值限定的范围表示时,这应当被理解为具体公开了由任何范围上限或优选值与任何范围下限或优选值的任一配对所形成的所有范围,而不论该范围是否单独公开了。例如,当公开了范围“1至5”时,所描述的范围应被解释为包括范围“1至4”、“1至3”、“1至2”、“1至2和4至5”、“1至3和5”等。当数值范围在本文中被描述时,除非另外说明,否则该范围意图包括其端值和在该范围内的所有整数和分数。
单数形式包括复数讨论对象,除非上下文中另外清楚地指明。“任选的”或者“任意一种”是指其后描述的事项或事件可以发生或不发生,而且该描述包括事件发生的情形和事件不发生的情形。
说明书和权利要求书中的近似用语用来修饰数量,表示本发明并不限定于该具体数量,还包括与该数量接近的可接受的而不会导致相关基本功能的改变的修正的部分。相应的,用“大约”、“约”等修饰一个数值,意为本发明不限于该精确数值。在某些例子中,近似用语可能对应于测量数值的仪器的精度。在本申请说明书和权利要求书中,范围限定可以组合和/或互换,如果没有另外说明这些范围包括其间所含有的所有子范围。
本发明的第一个方面提供了一种抗幽门螺旋杆菌组合物,所述组合物的制备原料,按重量份计,至少包括以下组分:植物活性物质60-100份、益生元30-80份、益生菌10-40份;所述植物活性物质至少包括百里香提取物。
在一种优选的实施方式中,所述抗幽门螺旋杆菌组合物的制备原料,按重量份计,包括以下组分:植物活性物质80-100份、益生元40-60份、益生菌20-30份;所述植物活性物质至少包括百里香提取物。
植物活性物质
植物活性物质是指采用适当的溶剂或方法,从植物(植物全部或者某一部分)为原料提取或加工而成的物质,可用于医药行业、食品行业、健康行业、美容行业以及其它行业。植物提取物是以植物为原料,按照对提取的最终产品的用途的需要,经过物理化学提取分离过程,定向获取和浓集植物中的某一种或多种有效成分,而不改变其有效成分结构而形成的产品。按照提取植物的成份不同,形成甙、酸、多酚、多糖、萜类、黄酮、生物碱等;按照性状不同,可分为植物油、浸膏、粉、晶状体等。
百里香提取物
百里香精油的化学成分因其种类及其分布区的不同而呈现多型性,这种多型性也可以作为分类的依据。魏春雁等根据该属植物化学成分的多型性,将兴安百里香划分为五种类型,即倍半萜烯/龙脑/樟脑型、倍半萜烯/樟脑/龙脑/单萜醇型、倍半萜烯型、桉油精/芳樟醇/龙脑型和单萜/倍半萜烯型;将五肋百里香分为酚型、芳樟醇型和混合型三种类型;将黑龙江百里香分为酚/萜醇混合型和萜烯型两种类型。
本发明中,所述百里香提取物的来源,没有特别的限制,市售均适用于本发明。
本发明中,所述植物活性物质还包括姜黄提取物、甘蓝提取物、桑葚提取物、菊苣提取物、佛手提取物、蒲公英提取物、石斛提取物、灵芝提取物、丁香提取物、陈皮提取物、桑叶提取物、茯苓提取物、芡实提取物、沙参提取物、黄精提取物、蒲公英提取物、柠檬提取物、西蓝花提取物、金银花提取物、绿茶提取物、猴头菇提取物、薄荷提取物、甘草提取物、红景天提取物、枸杞提取物、虫草菌提取物、黄芪提取物、薏仁提取物、山楂提取物、山药提取物、连翘提取物、苦参提取物、黄连提取物、板蓝根提取物中的至少一种。
在一种更优选的实施方式中,所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,重量比为1:(0.5-5):(0.1-2):(0.5-3):(0.1-1.5):(0.05-1)。
在一种最优选的实施方式中,所述姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的重量比为1:4:1.2:1.8:1:0.3。
姜黄提取物
姜黄提取物的主要成分为姜黄素。姜黄素是植物界很稀少的具有二酮的色素,为二酮类化合物。姜黄素为橙黄色结晶粉末,味稍苦,不溶于水,在食品生产中主要用于肠类制品、罐头、酱卤制品等产品的着色。医学研究表明,姜黄素具有降血脂、抗肿瘤、抗炎、利胆、抗氧化等作用。
本发明中,所述姜黄提取物的来源,没有特别的限制,市售均适用于本发明。
苦参提取物
苦参,中药名。为豆科植物苦参的干燥根,春、秋二季采挖,除去根头和小支根,洗净,干燥,或趁鲜切片,干燥。其苦,寒。有清热燥湿,杀虫,利尿之功。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外治滴虫性阴道炎。苦参提取物从豆科苦参属的植物苦参Sophoraflavescens中提取的一种生物碱。其原材根部质坚韧,断面粗纤维性,黄白色。气微,味极苦。
本发明中,所述苦参提取物的来源,没有特别的限制,市售均适用于本发明。
黄芪提取物
黄芪提取物为豆科植物黄芪Astragalusmembranaceus(Fisch.)Bge.的干燥根提取物。具有增强免疫力,增强能量,抗疲劳,抗突变,保肝,抑制破骨细胞的作用。黄芪多糖具有降血脂,即降低胆固醇和甘油三酯、升高高密度脂蛋白的作用;能够预防和治疗心脑血管疾病,如动脉粥样硬化、冠状动脉病变、周围血管病变以及高脂血症等。黄芪甲苷具有显著降低血糖、糖化血红蛋白和尿蛋白的作用,可降低肾皮质和血清中的AGEs,显示黄芪甲苷具有抗氧化作用,并对醛糖还原酶有抑制作用,还有抑制系膜细胞增生、减轻肾脏肥大的作用。在黄芪甲苷中加入适当辅料,可制成口服制剂,它用于预防和治疗糖尿病肾病。
本发明中,所述黄芪提取物的来源,没有特别的限制,市售均适用于本发明。
蒲公英提取物
蒲公英在播种时会变成蓬松的绒毛球状的可爱亮黄色小花并覆盖许多类型的土地。其有锯齿的叶从围绕着黄色花朵的圆花饰长出,可长到12英寸长。花瓣在白天打开,晚上关闭。在覆盖其容貌的种子头状物中含有超过200颗种子。当折断其茎部时会泄漏一种粘稠牛奶状物质。蒲公英提取物被用于治疗肝脏和胆囊阻塞,改善肝功能,促进胆汁分泌和作为利尿剂使用。
本发明中,所述蒲公英提取物的来源,没有特别的限制,市售均适用于本发明。
黄连提取物
黄连提取物,多集聚成簇,常弯曲,形如鸡爪,单枝根茎长3~6cm,直径0.3~0.8cm。表面灰黄色或黄褐色,粗糙。清热燥湿,泻火解毒。用于湿热痞满,呕吐吞酸,泻痢,黄疽,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疗疮;外治湿疹,湿疮,耳道流脓。
本发明中,所述黄连提取物的来源,没有特别的限制,市售均适用于本发明。
发明人发现,本发明采用姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的复配,能够产生协同增效的作用,有效抑制和杀灭幽门螺旋杆菌,提高远期疗效减少复发,削弱幽门螺旋杆菌的毒性,保护口腔卫生,预防胃病的发生。然而发明人意外发现,姜黄提取物的主要活性成分姜黄素稳定性差、吸收率低,且在体液的作用下容易转化为葡糖苷醛酸和磺酸等酸类复合物,降低组合物对幽门螺旋杆菌的抑制效果,而与苦参提取物和黄连提取物等复配使用后,能够明显提高姜黄素的稳定性和组合物对幽门螺旋杆菌的抑制效果。发明人认为可能的原因是,苦参提取物和黄连提取物的主要活性成分为生物碱类物质,如苦参中的参碱、氧化苦参碱、羟基苦参碱、N-甲基金雀花碱等,黄连中的小檗碱、黄连碱(coptisine),表小檗碱、小檗红碱、掌叶防已碱、非洲防己碱、药根碱、甲基黄连碱和木兰花碱等,碱性条件下姜黄素发生电子云偏离的共轭效应,从而将姜黄素中的酚羟基转化为酚盐,并与植物活性物质中的微量金属原子结合,不仅降低游离金属原子毒性,提高姜黄素在体液中的溶解性和稳定性,还提高了姜黄素清除活性氧族的能力和药理活性,从而进一步提高组合物抑制和杀灭幽门螺旋杆菌的效果。
然而,姜黄提取物本身具有苦味和辣味,在生物碱的存在的条件下,苦涩和辛辣味更为明显,导致组合物的适口性差,严重限制了其在食品等领域的应用。发明人在研究过程中意外发现,复配一定量的百里香提取物能够有效改善组合物适口性的问题,提高组合物的应用范围。发明人认为可能的原因是,姜黄素分子两端具有两个羟基,在碱性条件下发生电子云偏离的共轭效应,因此苦涩口感更加明显,而百里香提取物富含分为百里香酚、香荆芥酚、芳樟醇和对-聚伞花素等化合物能够刺激口腔的味觉器官,且本身具有强烈的香味,对生物碱和姜黄素产生的苦涩和辛辣具有明显的掩盖和模糊作用,能够丰富和改善组合物的口味,提高适口性。
益生菌
益生菌是通过定殖在人体内,改变宿主某一部位菌群组成的一类对宿主有益的活性微生物。通过调节宿主黏膜与系统免疫功能或通过调节肠道内菌群平衡,促进营养吸收保持肠道健康的作用,从而产生有利于健康作用的单微生物或组成明确的混合微生物。
本发明中,所述益生菌选自嗜酸乳杆菌、保加利亚乳杆菌、植物乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、干酪乳杆菌、格氏乳杆菌、约氏乳杆菌、唾液乳杆菌、短乳杆菌、乳酸链球菌、枯草芽孢杆菌、两歧双歧杆菌、青春双歧杆菌、婴儿双歧杆菌、短双歧杆菌、长双歧杆菌、罗门螺杆菌、乳双歧杆菌、格式乳杆菌、纹膜醋杆菌、木葡糖醋酸杆菌、啤酒片球菌、酿酒酵母、嗜热链球菌、米曲霉菌、安卡红曲霉、乳酸乳球菌中的至少一种。
在一种优选的实施方式中,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:(0.5-2)。
在一种更优选的实施方式中,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:1.5。
植物乳杆菌
植物乳杆菌是乳酸菌的一种,最适生长温度为30~35,厌氧或兼性厌氧,菌种为直或弯的杆状,单个、有时成对或成链状,最适pH6.5左右,属于同型发酵乳酸菌。革兰氏阳性,不生芽孢。兼性厌氧,表面菌落直径约3mm,凸起,呈圆形,表面光滑,细密,色白,偶尔呈浅黄或深黄色。属化能异养菌,生长需要营养丰富的培养基,需要泛酸钙和烟酸,但不需要硫胺素、吡哆醛或吡哆胺、叶酸、维生素B12。能发酵戊糖或葡萄糖酸盐,终产物中85%以上是乳酸。通常不还原硝酸盐,不液化明胶,接触酶和氧化酶皆阴性。能产生DL一乳酸,有1,6~二磷酸果糖醛缩酶和单磷酸己糖途径的活性,能在葡萄酸盐中生长,并产CO2。发酵1分子的核糖或其他的戊糖生成1分子的乳酸和1分子的乙酸。
本发明中,所述植物乳杆菌的来源,没有特别的限制,市售均适用于本发明。
唾液乳酸杆菌
刺激免疫细胞分泌抗过敏相关细胞激素浓度的唾液乳杆菌。是革兰氏染色阳性杆菌,不生成孢子,不具触酶、氧化酶及运动性,在好氧及厌氧环境均能生长,属于兼性异质发酸性菌株,葡糖代谢时不产生气体。唾液乳杆菌适合在兼性厌氧或绝对厌氧下生长,生长最适温度30~43℃,最适pH值5.0~5.5或更低,最适合生长温度在37℃上下。在厌氧环境生长较佳,产乳酸,具耐酸性,可耐酸至pH值2.5及耐胆盐至0.4%,4小时。
本发明中,所述唾液乳杆菌的来源,没有特别的限制,市售均适用于本发明。
发明人发现,植物活性物质经吞咽进入胃肠道后,逐渐被胃酸分解,使组合物在胃肠道内的抗幽门螺旋杆菌的时效大大降低,而复配一定量的益生菌,不仅能够提高组合物在胃肠道内抗幽门螺旋杆菌的时果,还可以维护肠道正常细菌菌群平衡,修复胃黏膜损伤,形成保护屏障。尤其是采用植物乳杆菌和唾液乳杆菌复配时,效果更加明显。发明人认为可能的原因是,首先,植物乳杆菌和唾液乳杆菌复配后产生的共生菌群酵素含有大量的花青素ANC和原花青素PAC,能够抑制a-葡萄糖苷酶(a-glucosidase)和二肽基肽酶4(dipeptidylpeptidase-IV)的活性,从而抑制幽门螺旋杆菌的繁殖;其次,幽门螺旋杆菌菌体表面的尿素酶通过分解宿主体内的尿素转变成氨来中和胃酸,保护菌体免受伤害,而植物乳杆菌、唾液乳杆菌通过产生有机酸(例如乳酸、乙酸、过氧化氢)和抑菌素,能够抑制尿素酶的活性,破坏幽门螺旋杆菌所产生的“氨云”保护层,使之无法抵抗胃液的杀菌作用,杀灭幽门螺旋杆菌;另外,唾液乳杆菌能分泌蛋白作为介质,与胃肠道上皮细胞受体连接,从而定植于动物体内,阻断病原菌与胃肠道上皮细胞的粘附,减少幽门螺旋杆菌的定殖量,与幽门螺旋杆菌竞争胃黏膜上皮表面的附着空间,使胃幽门螺旋杆菌彻底失去生存优势。
益生元
目前,常用的益生元有低聚糖类,包括低聚果糖、低聚半乳糖、低聚木糖、低聚异麦芽糖、大豆低聚糖、菊粉等,有些微藻类也可作为益生元,如螺旋藻、节旋藻等,此外多糖(如云芝多糖,胡萝含氮多糖)、蛋白质水解物(如酪蛋白的水解物,α-乳清蛋白,乳铁蛋白等)以及天然植物中的蔬菜、中草药、野生植物等也能作为益生元使用。
本发明中,所述益生元选自木糖醇、山梨糖醇、乳糖醇、乳果糖、乳蔗糖、蜜二糖、木二糖、水苏糖、蜜三糖、低聚果糖、低聚半乳糖、低聚异麦芽糖、低聚木糖、低聚异麦芽酮糖、低聚龙胆糖、阿拉伯半乳聚糖、果胶、普鲁兰多糖、菊粉、木素中的至少一种。
在一种优选的实施方式中,所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:(1-5):(1-5)。
在一种更优选的实施方式中,所述低聚半乳糖、水苏糖和果胶中的重量比为1:3:5。
低聚半乳糖
低聚半乳糖(Galactooligosaccharides,GOS)是一种具有天然属性的功能性低聚糖,其分子结构一般是在半乳糖或葡萄糖分子上连接1~7个半乳糖基,即Gal-(Gal)n-Glc/Gal(n为0-6)。在自然界中,动物的乳汁中存在微量的GOS,而人母乳中含量较多,婴儿体内的双歧杆菌菌群的建立很大程度上依赖母乳中的GOS成分。
本发明中,所述低聚半乳糖的来源,没有特别的限制,市售均适用于本发明。
水苏糖
水苏糖是天然存在的一种四糖,是一种可以显著促进双歧杆菌等有益菌增殖的功能性低聚糖。纯品为白色粉末,味稍甜,甜度为蔗糖的22%,味道纯正,无任何不良口感或异味。其分子结构:“半乳糖-半乳糖-葡萄糖-果糖”。
本发明中,所水苏糖的来源,没有特别的限制,市售均适用于本发明。
果胶
果胶是一种多糖,其组成有同质多糖和杂多糖两种类型。它们多存在于植物细胞壁和细胞内层,大量存在于柑橘、柠檬、柚子等果皮中。白色至黄色粉状,相对分子质量约20000~400000,无味。在酸性溶液中较在碱性溶液中稳定,通常按其酯化度分为高酯果胶及低酯果胶。高酯果胶在可溶性糖含量≥60%、pH=2.6~3.4的范围内形成非可逆性凝胶。低酯果胶一部分甲酯转变为伯酰胺,不受糖、酸的影响,但需与钙、镁等二价离子结合才能形成凝胶。
本发明中,所述果胶的来源,没有特别的限制,市售均适用于本发明。
发明人认为,幽门螺杆菌利用它的螺旋状结构,钻透胃黏膜表面的黏液,寄生在黏液中靠近胃黏膜上皮的相对中性的环境中,若益生菌的量不足以抗衡幽门螺旋杆菌时,其抑制效果并没有明显的提高。然而,蒲公英提取物中富含菊糖、果糖葡萄糖等糖类物质,能够促进益生菌的生长,在口腔中具有显著的增效作用,但随着其进入胃肠道后被胃液消化,增效作用逐渐减小。而复配一定量益生元糖类物质,能够被分解吸收,促进益生菌的生长繁殖。尤其采用低聚半乳糖、水苏糖和果胶的组合,能够在少量添加的情况下达到最佳的效果,增强胃肠蠕动,促进营养吸收的功能,特别是当果胶的含量占益生元的50wt%以上,能够在胃黏膜上形成一层益生元膜层,显著增加益生菌的定殖,对乳杆菌有明显的增殖作用,竞争性抑制幽门螺旋杆菌的生长,且有益菌代谢产生的短链脂肪酸和一些抗菌物质可直接抑制幽门螺旋杆菌的生长繁殖,改善肠道内微生物种群比例,并逐渐出现乳酸杆菌的“过剩生长”,促进形成有益菌在消化道内的优势菌地位,同时产生大量生理活性物质,并且分解衍生出多重免疫功能因子,进一步加速幽门螺旋杆菌的灭亡。同时,复配一定量的低聚半乳糖、水苏糖和果胶,不仅能够调节组合物的口味,进一步改善组合物的适口性,还能够提高组合物应用到产品中的溶解性和分散性,提高组合物的利用效率。
本发明中,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:(0.5-2)。
在一种优选的实施方式中,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:2。
发明人发现,由于每个人的体质不同,很多人由于乳糖酶分泌少对乳糖不耐受,引起的非感染性腹泻等症状。而复配一定量的植物乳杆菌,不仅具有一定的免疫调节,抑制幽门螺旋杆菌,维持肠道内菌群平衡,促进营养物质吸收的作用,同时还能够补充酸性乳糖酶,缓解乳糖不耐症,并局部产生大量的酸,降解幽门螺旋杆菌的“氨云”保护层,进一步瓦解幽门螺旋杆菌的生存条件,加速其灭亡。其次,植物乳杆菌在繁殖的过程中能够产生特有的乳酸杆菌素,协同姜黄提取物中大量的姜黄素,能够显著提高组合物的稳定性和保质期,且植物活性物质含有大量的抗氧化类物质,能够起到抗氧化防护作用,保持益生菌的活性;另外,百里香提取物、蒲公英提取物、低聚半乳糖、水苏糖和果胶的复配,不仅能够改善组合物的适口性,还能够提高组合物的使用范围。
本发明的第二个方面提供了所述抗幽门螺旋杆菌组合物的应用,应用于食品、日化用品领域。
在一种优选的实施方式中,所述抗幽门螺旋杆菌组合物可应用于各类食品、牙膏、爆珠糖、口腔喷剂、牙粉、漱口水、泡腾片。
在一种更优选的实施方式中,所述抗幽门螺旋杆菌的添加量为0.1-20wt%。
本发明的第三个方面提供了所述抗幽门螺旋杆菌组合物的制备方法,包括以下步骤:将植物活性物质、益生菌和益生元混合,搅拌均匀,即得。
下面通过实施例对本发明进行具体描述。有必要在此指出的是,以下实施例只用于对本发明作进一步说明,不能理解为对本发明保护范围的限制,该领域的专业技术人员根据上述本发明的内容做出的一些非本质的改进和调整,仍属于本发明的保护范围。
另外,如果没有其它说明,所用原料都是市售的。
实施例
实施例1
实施例1提供了一种抗幽门螺旋杆菌组合物,所述组合物的制备原料,按重量份计,包括以下组分:植物活性物质90份、益生元50份、益生菌25份。
所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,1:4:1.2:1.8:1:0.3;所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:1.5;所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:3:5。
所述抗幽门螺旋杆菌组合物的制备方法,包括以下步骤:将植物活性物质、益生菌和益生元混合,搅拌均匀,即得。
实施例2
实施例2提供了一种抗幽门螺旋杆菌组合物,所述组合物的制备原料,按重量份计,包括以下组分:植物活性物质60份、益生元30份、益生菌10份。
所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,1:0.5:0.1:0.5:0.1:0.05;所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:0.5;所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:1:1。
所述抗幽门螺旋杆菌组合物的制备方法,包括以下步骤:将植物活性物质、益生菌和益生元混合,搅拌均匀,即得。
实施例3
实施例3提供了一种抗幽门螺旋杆菌组合物,所述组合物的制备原料,按重量份计,包括以下组分:植物活性物质100份、益生元60份、益生菌20份。
所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,1:5:2:3:1.5:1;所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:2;所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:5:5。
所述抗幽门螺旋杆菌组合物的制备方法,包括以下步骤:将植物活性物质、益生菌和益生元缓和搅拌均匀,即得。
实施例4
实施例4与实施例1的区别在于,不包括姜黄提取物。
实施例5
实施例5与实施例1的区别在于,不包括百里香提取物。
实施例6
实施例6与实施例1的区别在于,不包括苦参提取物。
实施例7
实施例7与实施例1的区别在于,不包括黄芪提取物。
实施例8
实施例8与实施例1的区别在于,不包括蒲公英提取物。
实施例9
实施例9与实施例1的区别在于,不包括黄连提取物。
实施例10
实施例10与实施例1的区别在于,姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物,重量比为1:0.5:1.2:1.8:1:0.3。
实施例11
实施例11与实施例1的区别在于,不包括植物乳杆菌。
实施例12
实施例12与实施例1的区别在于,不包括唾液乳杆菌。
实施例13
实施例13与实施例1的区别在于,将植物乳杆菌替换为鼠李糖乳杆菌。
实施例14
实施例14与实施例1的区别在于,将唾液乳杆菌替换为乳双歧杆菌。
实施例15
实施例15与实施例1的区别在于,不包括果胶。
实施例16
实施例16与实施例1的区别在于,所述低聚半乳糖、水苏糖和果胶中的重量比为1:3:0.5。
实施例17
实施例17与实施例1的区别在于,不包括低聚半乳糖。
实施例18
实施例18与实施例1的区别在于,将低聚半乳糖替换为低聚果糖。
实施例19
实施例19与实施例1的区别在于,不包括水苏糖。
性能测试
一、抑菌率
1.将实施例1-19制得的抗幽门螺旋杆菌组合物制备成口腔喷剂,测试口腔喷剂的抑菌效果。
所述口腔喷剂的制备原料,按重量份计,包括以下组分:水60份、山梨糖醇10份、薄荷醇5份、氢化蓖麻油10份、木糖醇1-5份、苯甲酸钠5份、香精5份、柠檬酸0.2份、抗幽门螺旋杆菌组合物20份。
所述口腔喷剂的制备方法,包括以下步骤:将水、山梨糖醇、薄荷醇、氢化蓖麻油、木糖醇、苯甲酸钠、香精、柠檬酸和抗幽门螺旋杆菌组合物混合,搅拌均匀,即得。
1.实验材料:
实施例1-19制备得到的口腔喷剂。
2.实验菌株:幽门螺杆菌临床菌株来自上海消化病研究所,经快速尿素酶、涂片革兰氏染色、氧化酶和触酶鉴定为阳性后,传代纯培养,所得菌株作为实验菌株。
3.实验方法
(1)菌株培养方法:采用微需氧袋进行幽门螺旋杆菌的菌株培养。
(2)菌液的制备方法:将幽门螺旋杆菌菌株取出,用无菌生理盐水进行清洗后,加入脑心浸液溶液配制成脑心浸液幽门螺旋杆菌菌悬液,再用标准比浊管进行比浊,以校正其菌液浓度,使菌液浓度达到1×108CFU·ml-1。
(3)抑菌实验:
分别量取一定量实施例1-19制得的口腔喷剂,然后分别加入到装有液体培养基试管中,备用。
分别量取细菌悬液1mL分别加入到含实施例1-19制得的口腔喷剂的试管中,并设置一个空白对照例(无口腔喷剂);同时置于37℃,微需氧环境(85%N2、10%CO2、5%O2)下培养24小时;再从各试管中多点接种器吸取材料;经适当稀释后涂布于脑心浸液琼脂培养基平板上,于37℃微需氧环境(85%N2、10%CO2、5%O2)下培养24小时,观察并计算平板上存活菌落数;空白对照例在平板上菌落数计为起始菌落数。
杀菌率计算公式:抑菌率(%)=(阳性对照OD值-试验OD值)/(阳性对照OD值-阴性对照OD值)×100。
(OD值是表示被检测物吸收掉的光密度,检测单位用OD值表示,1OD=1og(1/T),其中T为检测物的透光值。)
Anthos酶标仪检测值,仪器要做重复性检查,对同一孔用470nm波长,酶标仪进行的中心定位,中心定位是要消除酶标孔底的凸凹引起的厚薄不均带来检测的不准确。参考波长630nm连续测5次,取最高OD值H、最低OD值L,计算重复误差率dev=H-L/(H+L),重复误差率≤0.5%。仪器定义没有光源下的透光值为0%,没有检测物的透光值为100%。则实际检测中,检测物的透光值均在0%-100%之间。使用同一酶标板反应的试剂检测结果才能比较和分析,通过“数据处理”程序模块数据取出,完成OD值的提取。计算如下:T=(Meas-Min)/(Max-Min),OD=1og(1/T)。
抑菌率测试结果见表1。
表1.实施例1-19制备得到的口腔喷剂的抑菌率测试结果
二、口腔喷剂的稳定性
感官测试:将实施例1-19制备得到的口腔喷剂常温放置两周,肉眼观察产品的性状,看是否有异常;判断标准:无沉淀或极少量沉淀,未出现变稀、变色等现象,则判定为稳定性好;少量沉淀,未出现变稀、变色等现象,则判定为稳定性一般;大量沉淀,并伴有变稀、变色、分层等现象,则判定为稳定性差。
测试结果见表2。
表2.实施例1-19制备得到的口腔喷剂的稳定性测试结果
三、口腔喷剂的适口性
选取1名志愿者,每天评价1个实施例制得的口腔喷剂的适口性,每个实施例制得的口腔喷剂的评价周期为一天;每天1上午喷一次待评价的口腔喷剂(每次使用量约为0.5mL),并在口中停留至少3分钟,判断待测口腔喷剂的适口性,判断标准如下:
入口后无苦涩感,记为好;入口后有轻微苦涩感,记为较好;入口后有苦涩感,但可以接受,记为一般;入口后苦涩感严重,难以接受,记为差。
测试结果见表3。
表3.实施例1-19制得的口腔喷剂的适口性测试结果
前述的实例仅是说明性的,用于解释本发明所述方法的一些特征。所附的权利要求旨在要求可以设想的尽可能广的范围,且本文所呈现的实施例仅是根据所有可能的实施例的组合的选择的实施方式的说明。因此,申请人的用意是所附的权利要求不被说明本发明的特征的示例的选择限制。在权利要求中所用的一些数值范围也包括了在其之内的子范围,这些范围中的变化也应在可能的情况下解释为被所附的权利要求覆盖。
Claims (10)
1.一种抗幽门螺旋杆菌组合物,其特征在于,所述组合物的制备原料,按重量份计,至少包括以下组分:植物活性物质60-100份、益生元30-80份、益生菌10-40份;所述植物活性物质至少包括百里香提取物。
2.根据权利要求1所述的抗幽门螺旋杆菌组合物,其特征在于,所述植物活性物质还包括姜黄提取物、甘蓝提取物、桑葚提取物、菊苣提取物、佛手提取物、蒲公英提取物、石斛提取物、灵芝提取物、丁香提取物、陈皮提取物、桑叶提取物、茯苓提取物、芡实提取物、沙参提取物、黄精提取物、蒲公英提取物、柠檬提取物、西蓝花提取物、金银花提取物、绿茶提取物、猴头菇提取物、薄荷提取物、甘草提取物、红景天提取物、枸杞提取物、虫草菌提取物、黄芪提取物、薏仁提取物、山楂提取物、山药提取物、连翘提取物、苦参提取物、黄连提取物、板蓝根提取物中的至少一种。
3.根据权利要求2所述的抗幽门螺旋杆菌组合物,其特征在于,所述植物活性物质为姜黄提取物、百里香提取物、苦参提取物、黄芪提取物、蒲公英提取物和黄连提取物的组合,重量比为1:(0.5-5):(0.1-2):(0.5-3):(0.1-1.5):(0.05-1)。
4.根据权利要求1所述的抗幽门螺旋杆菌组合物,其特征在于,所述益生元选自木糖醇、山梨糖醇、乳糖醇、乳果糖、乳蔗糖、蜜二糖、木二糖、水苏糖、蜜三糖、低聚果糖、低聚半乳糖、低聚异麦芽糖、低聚木糖、低聚异麦芽酮糖、低聚龙胆糖、阿拉伯半乳聚糖、果胶、普鲁兰多糖、菊粉、木素中的至少一种。
5.根据权利要求4所述的抗幽门螺旋杆菌组合物,其特征在于,所述益生元为低聚半乳糖、水苏糖和果胶中的组合,重量比为1:(1-5):(1-5)。
6.根据权利要求1所述的抗幽门螺旋杆菌组合物,其特征在于,所述益生菌选自嗜酸乳杆菌、保加利亚乳杆菌、植物乳杆菌、鼠李糖乳杆菌、罗伊氏乳杆菌、干酪乳杆菌、格氏乳杆菌、约氏乳杆菌、唾液乳杆菌、短乳杆菌、乳酸链球菌、枯草芽孢杆菌、两歧双歧杆菌、青春双歧杆菌、婴儿双歧杆菌、短双歧杆菌、长双歧杆菌、罗门螺杆菌、乳双歧杆菌、格式乳杆菌、纹膜醋杆菌、木葡糖醋酸杆菌、啤酒片球菌、酿酒酵母、嗜热链球菌、米曲霉菌、安卡红曲霉、乳酸乳球菌中的至少一种。
7.根据权利要求6所述的抗幽门螺旋杆菌,其特征在于,所述益生菌为植物乳杆菌和唾液乳杆菌的组合,重量比为1:(0.5-2)。
8.根据权利要求1所述的抗幽门螺旋杆菌组合物,其特征在于,所述益生元和益生菌的重量比为(1-5):1。
9.一种根据权利要求1-8任一项所述的抗幽门螺旋杆菌组合物的应用,其特征在于,应用于食品、日化用品领域。
10.根据权利要求9所述的抗幽门螺旋杆菌组合物的应用,其特征在于,所述抗幽门螺旋杆菌组合物的添加量为0.1-20wt%。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010892402.2A CN111820407A (zh) | 2020-08-31 | 2020-08-31 | 一种抗幽门螺旋杆菌组合物及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010892402.2A CN111820407A (zh) | 2020-08-31 | 2020-08-31 | 一种抗幽门螺旋杆菌组合物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111820407A true CN111820407A (zh) | 2020-10-27 |
Family
ID=72918708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010892402.2A Withdrawn CN111820407A (zh) | 2020-08-31 | 2020-08-31 | 一种抗幽门螺旋杆菌组合物及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111820407A (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112603966A (zh) * | 2021-01-13 | 2021-04-06 | 刘萌 | 一种治疗幽门螺旋杆菌逆转肠化生的中药茶剂及制备方法 |
CN112716840A (zh) * | 2020-12-29 | 2021-04-30 | 李雪静 | 一种抑制幽门螺旋杆菌组合物及其制备方法及用途 |
CN114259055A (zh) * | 2021-11-02 | 2022-04-01 | 郑州和合生物工程技术有限公司 | 一种拮抗幽门螺旋杆菌的组合物 |
CN114392337A (zh) * | 2021-12-30 | 2022-04-26 | 汤臣倍健股份有限公司 | 一种对胃黏膜损伤有辅助保护功能的组合物及其应用 |
CN114525222A (zh) * | 2022-03-02 | 2022-05-24 | 山东拜因诺生物科技有限公司 | 一种抑幽益生菌 |
CN114668707A (zh) * | 2022-02-25 | 2022-06-28 | 李自鹏 | 一种可以康复口腔异味的益生菌口腔抑菌膏 |
CN114831910A (zh) * | 2022-04-06 | 2022-08-02 | 广州盛景家庭服务有限公司 | 一种用于幽门螺旋杆菌的口腔抑菌膏 |
CN116076736A (zh) * | 2023-04-07 | 2023-05-09 | 北京东方红航天生物技术股份有限公司 | 一种抗幽养胃组合物及其应用 |
CN116492285A (zh) * | 2023-06-29 | 2023-07-28 | 深圳市波尔顿科技有限公司 | 一种用于口腔的复合益生菌组合物及其应用和产品 |
CN118490726A (zh) * | 2024-07-19 | 2024-08-16 | 杭州菌吾细研生物科技有限公司 | 酿酒酵母s-16的应用及其组合物和复合微生物制剂 |
-
2020
- 2020-08-31 CN CN202010892402.2A patent/CN111820407A/zh not_active Withdrawn
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112716840A (zh) * | 2020-12-29 | 2021-04-30 | 李雪静 | 一种抑制幽门螺旋杆菌组合物及其制备方法及用途 |
CN112603966A (zh) * | 2021-01-13 | 2021-04-06 | 刘萌 | 一种治疗幽门螺旋杆菌逆转肠化生的中药茶剂及制备方法 |
CN114259055A (zh) * | 2021-11-02 | 2022-04-01 | 郑州和合生物工程技术有限公司 | 一种拮抗幽门螺旋杆菌的组合物 |
CN114392337A (zh) * | 2021-12-30 | 2022-04-26 | 汤臣倍健股份有限公司 | 一种对胃黏膜损伤有辅助保护功能的组合物及其应用 |
CN114668707A (zh) * | 2022-02-25 | 2022-06-28 | 李自鹏 | 一种可以康复口腔异味的益生菌口腔抑菌膏 |
CN114525222A (zh) * | 2022-03-02 | 2022-05-24 | 山东拜因诺生物科技有限公司 | 一种抑幽益生菌 |
CN114831910A (zh) * | 2022-04-06 | 2022-08-02 | 广州盛景家庭服务有限公司 | 一种用于幽门螺旋杆菌的口腔抑菌膏 |
CN116076736A (zh) * | 2023-04-07 | 2023-05-09 | 北京东方红航天生物技术股份有限公司 | 一种抗幽养胃组合物及其应用 |
CN116492285A (zh) * | 2023-06-29 | 2023-07-28 | 深圳市波尔顿科技有限公司 | 一种用于口腔的复合益生菌组合物及其应用和产品 |
CN116492285B (zh) * | 2023-06-29 | 2023-09-22 | 深圳市波尔顿科技有限公司 | 一种用于口腔的复合益生菌组合物及其应用和产品 |
CN118490726A (zh) * | 2024-07-19 | 2024-08-16 | 杭州菌吾细研生物科技有限公司 | 酿酒酵母s-16的应用及其组合物和复合微生物制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111820407A (zh) | 一种抗幽门螺旋杆菌组合物及其应用 | |
CN109628358A (zh) | 一种复合益生菌及其应用 | |
US7247325B2 (en) | Crude drug compositions and the process for preparing them | |
KR101339706B1 (ko) | 홍삼 포접화합물, 면역 농축물 및 유산균을 유효성분으로 함유하는 면역증강 복합 조성물 | |
KR20140140387A (ko) | 나노형 김치 유산균 | |
CN117487683A (zh) | 具有抗幽护胃和消食化积功效的益生菌组合物及其应用 | |
KR20080075971A (ko) | 프로바이오틱스 복합 제제 | |
CN110447799A (zh) | 一种用于改善肠道菌群的复合固体植物饮料及其制备方法 | |
JP2005013211A (ja) | 乳酸菌含有食品組成物 | |
KR101677187B1 (ko) | 면역증진 및 장내환경개선용 건강기능성 음료 | |
KR101743043B1 (ko) | 장내환경개선효과를 갖는 나노형 김치 유산균 조성물 | |
KR101743044B1 (ko) | 면역증진 및 장내환경개선용 건강기능성 식품 | |
KR20200084829A (ko) | 나노화된 김치 유산균을 함유하는 항바이러스용 약학조성물 | |
KR20050053351A (ko) | 배당체 가수분해능을 가진 신규한 미생물, 이를 함유한프로바이오틱스 및 이의 제조방법 | |
KR101368634B1 (ko) | 산삼배양근 발효물을 유효성분으로 하는 숙취해소 및 면역증진용 건강기능식품 및 이의 제조방법 | |
KR102319714B1 (ko) | 신규 페디오코커스 펜토사세우스 균주를 이용한 새싹땅콩 발효물의 제조방법 및 상기 방법에 의해 제조된 새싹땅콩 발효물을 포함하는 변비 개선용 조성물 | |
KR100977076B1 (ko) | 오미자 추출물 및 복분자 추출물을 함유하는 항헬리코박터조성물 | |
KR20220141377A (ko) | 울금을 유효성분으로 포함하는 숙취해소용 환 및 이의 제조방법 | |
KR100545156B1 (ko) | 세균성 장질환 예방 및 치료용 생약조성물 | |
KR101074348B1 (ko) | 녹조류 추출물을 함유하는 항헬리코박터 조성물 | |
KR20120115894A (ko) | 피로관련 질환의 치료 및 예방을 위한 발효 조성물 | |
KR20140088970A (ko) | 황금엑스 발효물을 함유한 간손상 보호용 조성물 | |
KR102507602B1 (ko) | 침향 고상발효산물과 그 용도 및 제조방법 | |
CN116077607B (zh) | 一种抗幽门螺杆菌感染的益生菌发酵中药组合物及其应用 | |
KR102616744B1 (ko) | 발효 자몽추출물을 포함하는 장 건강 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20201027 |
|
WW01 | Invention patent application withdrawn after publication |